Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study.

Neurol Ther · 2021 · PMC8140173 · PMID 33835383

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an interesting trendno p-value reported

S6 (month 6).There is an interesting trend in all months for all treatment groups.

also in 1,783 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.